Abstract:Objective To investigate the effects of the long non-coding RNA FEZF1-AS1 (LncRNA FEZF1-AS1) on the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of cells in idiopathic pulmonary fibrosis (IPF) and its underlying mechanisms.Methods A549 cells were treated with Transforming growth factor-β1 (TGF-β1) to induce a pulmonary fibrosis cell model, dividing them into a blank control group (A549 cell group) and a model group. Western blotting was used to measure the expression of E-cadherin, N-cadherin, and Vimentin to verify the model's success. Real-time quantitative polymerase chain reaction (qRT-PCR) was employed to measure the expression of LncRNA FEZF1-AS1 and microRNA-200c-3p (miR-200c-3p). Based on experimental goals and different transfection plasmids, A549 cells were divided into three groups: Blank, TGF-β1 + Si LncRNA FEZF1-AS1 NC, and TGF-β1 + Si LncRNA FEZF1-AS1. Cell proliferation was evaluated using the CCK-8 assay, migration was assessed with wound healing assays, and invasion capabilities were measured using Transwell assays. Western blotting and qRT-PCR were repeated to assess protein and gene expression changes.Results In the model group, the relative expression of E-cadherin decreased, while N-cadherin and Vimentin increased compared to the blank control (P <0.05). LncRNA FEZF1-AS1 was upregulated, and miR-200c-3p was downregulated in the model group compared to the control (P <0.05). Compared to the Blank group, cell proliferation, migration, and invasion were increased in the TGF-β1 + Si LncRNA FEZF1-AS1 NC group (P <0.05). In contrast, these parameters were reduced in the TGF-β1 + Si LncRNA FEZF1-AS1 group compared to the NC group (P <0.05). Also, this group showed decreased expression of LncRNA FEZF1-AS1, N-cadherin, Vimentin, and increased E-cadherin compared to the NC group (P <0.05). The expression of miR-200c-3p was higher in the TGF-β1 + Si LncRNA FEZF1-AS1 and Blank groups compared to the NC group (P < 0.05).Conclusions LncRNA FEZF1-AS1 promotes the proliferation, migration, invasion, and EMT processes in pulmonary fibrosis cells by inhibiting miR-200c-3p.